Literature DB >> 10654798

Night-time quiescence and morning activation in the human colon: effect on transit of dispersed and large single unit formulations.

J M Hebden1, P J Gilchrist, E Blackshaw, M E Frier, A C Perkins, C G Wilson, R C Spiller.   

Abstract

OBJECTIVES: Controlling the delivery of drugs to different regions of the colon remains an elusive goal. The aim of this study was to define the diurnal variation in colonic transit and show how this influences the colonic distribution and residence time of different formulations given either in the morning or evening.
METHODS: Colonic transit of small particulates and a large capsule was measured during nocturnal sleep and daytime wakefulness. Eighteen healthy volunteers participated in a randomised crossover study. 111In-labelled resin (150-300 microm) and a large 99mTc-labelled non-disintegrating capsule (22 x 8 mm) were swallowed at either 0800h or 1700h. MAIN OUTCOME MEASURES: The geometric centre of isotope (range 1-9) was calculated from serial scintiscans allowing comparison of overnight and daytime transit.
RESULTS: Transit of resin was delayed in the overnight compared to daytime 8 h periods (change in geometric centres (GCs), mean +/- SEM, 0.59 +/- 0.14 vs 1.46 +/- 0.39 respectively, P < 0.02). Maximal resin movement occurred immediately after awakening, prior to breakfast, in 9/18 studies (P < 0.05). The capsule was more distal than the resin at the end of the study 15 h after dosing (P < 0.001). There was marked inter-individual variability in distribution of both resin and capsule at 15 h, the range of GCs being 2.8-9 and 2.2-9, respectively.
CONCLUSION: Sleep delays colonic transit and large capsules travel faster than dispersed small particles. However, substantial inter-individual variability in transit makes targeting specific regions of the human colon unreliable with either dispersed or single unit formulations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10654798     DOI: 10.1097/00042737-199912000-00007

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  6 in total

1.  Steady-state pharmacokinetics of a novel extended-release metformin formulation.

Authors:  Peter Timmins; Steve Donahue; Jeff Meeker; Punit Marathe
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

Review 2.  Advances in colonic drug delivery.

Authors:  Abdul W Basit
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Wireless pH-motility capsule for colonic transit: prospective comparison with radiopaque markers in chronic constipation.

Authors:  M Camilleri; N K Thorne; Y Ringel; W L Hasler; B Kuo; T Esfandyari; A Gupta; S M Scott; R W McCallum; H P Parkman; E Soffer; G E Wilding; J R Semler; S S C Rao
Journal:  Neurogastroenterol Motil       Date:  2010-05-11       Impact factor: 3.598

4.  Relative bioavailability and bioequivalence of metforphin hydrochloride extended-released and immediate-released tablets in healthy Chinese volunteers.

Authors:  Jun Li; Yong Jin; Ting-Yu Wang; Xiong-Wen Lü; Yuan-Hai Li
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2007 Jan-Mar       Impact factor: 2.441

5.  Application of In Vivo MRI Imaging to Track a Coated Capsule and Its Disintegration in the Gastrointestinal Tract in Human Volunteers.

Authors:  Sarah Sulaiman; Pavel Gershkovich; Caroline L Hoad; Matthew Calladine; Robin C Spiller; Snow Stolnik; Luca Marciani
Journal:  Pharmaceutics       Date:  2022-01-24       Impact factor: 6.321

6.  Safety, tolerability, and efficacy of metformin extended-release oral antidiabetic therapy in patients with type 2 diabetes: an observational trial in Asia.

Authors:  Chul-Hee Kim; Kyung-Ah Han; Han-Jin Oh; Kevin Eng-Kiat Tan; Radhakrishna Sothiratnam; Askandar Tjokroprawiro; Marcus Klein
Journal:  J Diabetes       Date:  2012-12       Impact factor: 4.006

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.